Cargando…
Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer
Deciphering principles of inter-tumoral heterogeneity is crucial for refinement of precision oncology. We have recently demonstrated that ‘oncogenic cooperation‘ between somatic mutations and regulatory germline variants can serve as a major cause for inter-tumoral heterogeneity, suggesting the requ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961672/ https://www.ncbi.nlm.nih.gov/pubmed/31993496 http://dx.doi.org/10.1080/23723556.2019.1682924 |
_version_ | 1783488031751143424 |
---|---|
author | Musa, Julian Grünewald, Thomas G. P. |
author_facet | Musa, Julian Grünewald, Thomas G. P. |
author_sort | Musa, Julian |
collection | PubMed |
description | Deciphering principles of inter-tumoral heterogeneity is crucial for refinement of precision oncology. We have recently demonstrated that ‘oncogenic cooperation‘ between somatic mutations and regulatory germline variants can serve as a major cause for inter-tumoral heterogeneity, suggesting the requirement of integrating the regulatory genome into ‘omics‘-based precision oncology. |
format | Online Article Text |
id | pubmed-6961672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-69616722020-09-28 Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer Musa, Julian Grünewald, Thomas G. P. Mol Cell Oncol Author's Views Deciphering principles of inter-tumoral heterogeneity is crucial for refinement of precision oncology. We have recently demonstrated that ‘oncogenic cooperation‘ between somatic mutations and regulatory germline variants can serve as a major cause for inter-tumoral heterogeneity, suggesting the requirement of integrating the regulatory genome into ‘omics‘-based precision oncology. Taylor & Francis 2019-11-06 /pmc/articles/PMC6961672/ /pubmed/31993496 http://dx.doi.org/10.1080/23723556.2019.1682924 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Author's Views Musa, Julian Grünewald, Thomas G. P. Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title | Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title_full | Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title_fullStr | Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title_full_unstemmed | Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title_short | Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
title_sort | interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer |
topic | Author's Views |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961672/ https://www.ncbi.nlm.nih.gov/pubmed/31993496 http://dx.doi.org/10.1080/23723556.2019.1682924 |
work_keys_str_mv | AT musajulian interactionbetweensomaticmutationsandgermlinevariantscontributestoclinicalheterogeneityincancer AT grunewaldthomasgp interactionbetweensomaticmutationsandgermlinevariantscontributestoclinicalheterogeneityincancer |